We are building an industry-leading team that combines cutting-edge academic science and drug discovery expertise. Our Founders, Scientific Advisory Board members, and other advisors are leaders in their fields and broadly recognized for their world-class research and record of accomplishment in neuroscience, metabolism, gut biology, and molecular biology. Our management and scientific teams include experts in our core technology areas and individuals with deep drug discovery know-how and a proven ability to translate science to products.
Team
Leadership Team
Founders
Board of Directors
Amy Schulman
Polaris Partners
Adam Goulburn, Ph.D.
Lux Capital
Tim Kutzkey, Ph.D.
The Column Group
Nancy Thornberry
Chair, R&D, Kallyope
William Rieflin
NGM Bio
Tom Maniatis, Ph.D.
Columbia University
Peter Hecht, Ph.D.
Tisento Therapeutics
Strategic Advisors
Tony Evnin, Ph.D.
Terry McGuire
Josh Wolfe
Lux Capital